Skip to main content

What Stryker's Quarter ended Sep 30, 2026 10-Q says: 4 signals

Stryker filed its latest 10-Q with the SEC on Oct 30, 2026. It discusses cybersecurity incident, goodwill impairment and restructuring.

Public (SYK)Medical Equipment Manufacturing10,000+ employeesstryker.comLinkedIn

Get Stryker's live signals in Claude or ChatGPT, or by API

AskWhat changed at Stryker this week? Use Autobound signals for stryker.com.
Filed
Oct 30, 2026
Period
Quarter ended Sep 30, 2026
Filings
3
Signals
10

Source: Autobound Signal API · 121 signals tracked for Stryker · updated

10-Q · latest 10

What Stryker's 10-Q filings say

  1. 10-Q · Quarter ended Sep 30, 2026

    Filed · 4 signals

    SEC EDGAR
  2. 10-Q · Quarter ended Jun 30, 2026

    Filed · 2 signals

    SEC EDGAR
  3. 10-Q · Quarter ended Mar 31, 2026

    Filed · 4 signals

    SEC EDGAR

Earnings calls

Stryker earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Organic sales grow 7.7%, adjusted EPS rises 10.3%Organic sales growth reached 7.7% in Q3, supported by 9.1% growth in MedSurg and Neurotechnology and 5.9% in Orthopaedics. Adjusted gross margin rose 40 basis points to 65.4%, while adjusted operating margin improved 60 basis points to 26.2%. Strong operational cash flows totaled $3.3 billion year-to-date, up 14%.
Full-year organic sales guidance lowered to 6.5%-7.0%Full-year organic net sales guidance was revised downward to 6.5% to 7.0% due to softer hip and knee procedural trends and lingering peripheral vascular supply constraints. Adjusted net EPS is now projected between $14.80 and $14.90, supported by disciplined expense control and gross margin expansion.
Acquisition of ZuriMED completed for soft tissue augmentationThe acquisition of ZuriMED was completed to expand soft tissue augmentation capabilities across sports medicine and arthroplasty portfolios. ZuriMED contributes proprietary FiberLocker technology designed to improve biomechanical fixation in rotator cuff repair procedures.
Endoscopy US organic sales surge 13% in Q3Endoscopy U.S. organic sales grew 13%, driven by capital demand for operating room infrastructure, hospital renovations, and sports medicine shoulder implants. International MedSurg and Neurotechnology sales also grew 7.2%, reflecting strong installations across global hospital systems.
SAP implementation completed across Orthopaedics division in JulyOrthopaedics finalized its enterprise resource planning transition onto SAP in July, marking the final operating unit to migrate. While the operational rollout experienced commercial disruption and delayed market visibility, the core enterprise system is now operating stably.
Sonopet 3 ultrasonic platform receives FDA 510(k) clearanceThe Sonopet 3 ultrasonic aspiration platform secured FDA 510(k) clearance in October, with launch scheduled ahead. Capital equipment deferrals in neurosurgery occurred during Q3 as hospitals prepared their budgets for the upcoming system deployment.

Signal API · MCP

Track Stryker with the Signal API

One POST /v1/companies/enrich call with stryker.com returns Stryker 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"stryker.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about Stryker 10-Q

When did Stryker file its latest 10-Q?
Stryker filed its latest 10-Q (Quarter ended Sep 30, 2026) on Oct 30, 2026. The one before it was filed on Jul 31, 2026.
What did Stryker disclose in its latest 10-Q?
From the filing dated Oct 30, 2026: First-quarter 2026 cybersecurity incident caused idle production time and elevated manufacturing and supply chain costs
What did Stryker say on its recent earnings calls?
Q3 FY2026: Organic sales grow 7.7%, adjusted EPS rises 10.3% (dated Oct 29, 2026).
Where can I read Stryker's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/syk-20260930.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →